Skip to content

filings.toolsA Dark Vector Cognition product

Item 6. EXHIBITS ( documents filed or furnished with this report; # compensatory plans or arrangements)

6K characters. Original on sec.gov ·

Item 6. EXHIBITS ( documents filed or furnished with this report; # compensatory plans or arrangements)





3.1						Fourth Restated Certificate of Incorporation of Boston Scientific Corporation (incorporated herein by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 5 , 202 6 , File No. 1-110183).

10.1						Employee Stock Purchase Plan, Amended and Restated Effective as of July 1, 202 6 (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 5 , 202 6 , File No.1-11083).

22						Subsidiary Issuer of Guaranteed Securities (incorporated herein by reference to Exhibit 22 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed on August 1, 2025, File No. 1-11083).


31.1*						Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*						Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1*						Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*						Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.SCH*						Inline XBRL Taxonomy Extension Schema Document.

101.CAL*						Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*						Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*						Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE*						Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104						Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August 3, 2026.


			BOSTON SCIENTIFIC CORPORATION
			By:			/s/ Jonathan Monson

						Name:			Jonathan Monson
						Title:			Executive Vice President and Chief Financial Officer

Previous: Item 5. OTHER INFORMATION